Sanofi (SNY) Cash from Discontinued Operations (2019 - 2025)

Sanofi (SNY) posted Cash from Discontinued Operations of 216512093.73 for Q4 2025, down 199.04% sequentially from 218613302.08 in Q3 2025.

Sanofi (SNY) Cash from Discontinued Operations (2019 - 2025) Analysis & Trends

Sanofi (SNY) has 7 years of Cash from Discontinued Operations data on file, last reported at 216512093.73 in Q4 2025.

  • Quarterly Cash from Discontinued Operations changed N/A year-over-year to 216512093.73 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 200095708.73 (changed N/A YoY) and the FY2025 annual result came in at 220004224.28, down 56.57% from the prior year.
  • Cash from Discontinued Operations declined to 216512093.73 in Q4 2025 per SNY's latest filing, from 218613302.08 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 12036862347.84 in Q4 2021, with the low at 216512093.73 in Q4 2025.
  • Average Cash from Discontinued Operations over 5 years is 3683393063.94, with a median of 194598621.31 recorded in 2025.
  • Year-over-year, Cash from Discontinued Operations jumped 36.1% in 2021 and sank 93.69% in 2025.
  • Sanofi's Cash from Discontinued Operations stood at 12036862347.84 in 2021, then declined by 10.78% to 10739123767.12 in 2022, then declined by 7.11% to 9975038896.17 in 2023, then tumbled by 99.46% to 53844378.81 in 2024, then sank by 502.11% to 216512093.73 in 2025.
  • Business Quant data shows SNY's Cash from Discontinued Operations at 216512093.73 in Q4 2025, 218613302.08 in Q3 2025, and 3395879.06 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 3.36 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -216.51 Mn
Dec 31, 2025 -216.51 Mn
Sep 30, 2025 218.61 Mn
Sep 30, 2025 218.61 Mn
Jun 30, 2025 3.40 Mn
Jun 30, 2025 3.40 Mn
Mar 31, 2025 194.60 Mn
Mar 31, 2025 194.60 Mn
Jun 30, 2024 53.84 Mn
Jun 30, 2024 53.84 Mn
Mar 31, 2024 145.57 Mn
Mar 31, 2024 145.57 Mn
Dec 31, 2023 9.98 Bn
Dec 31, 2023 9.98 Bn
Dec 31, 2022 10.74 Bn
Dec 31, 2022 10.74 Bn
Dec 31, 2021 12.04 Bn
Dec 31, 2021 12.04 Bn
Dec 31, 2020 8.84 Bn
Dec 31, 2020 8.84 Bn